May 18 2026HEALTH
Better Medicines for Rare Diseases: Fighting Hidden Bias in Health Decisions
How are life-saving treatments chosen? When governments decide which medicines to evaluate, they often overlook rare diseases. Most health plans focus on treatments that help large groups, leaving small patient communities behind. Rare disease drugs, called orphan medicinal products, rarely get fair
reading time less than a minute
